US5487739A
(en)
*
|
1987-11-17 |
1996-01-30 |
Brown University Research Foundation |
Implantable therapy systems and methods
|
US5418154A
(en)
*
|
1987-11-17 |
1995-05-23 |
Brown University Research Foundation |
Method of preparing elongated seamless capsules containing biological material
|
US5871472A
(en)
*
|
1987-11-17 |
1999-02-16 |
Brown University Research Foundation |
Planting devices for the focal release of neuroinhibitory compounds
|
US5283187A
(en)
*
|
1987-11-17 |
1994-02-01 |
Brown University Research Foundation |
Cell culture-containing tubular capsule produced by co-extrusion
|
US5269785A
(en)
*
|
1990-06-28 |
1993-12-14 |
Bonutti Peter M |
Apparatus and method for tissue removal
|
US5529914A
(en)
*
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
US5462990A
(en)
*
|
1990-10-15 |
1995-10-31 |
Board Of Regents, The University Of Texas System |
Multifunctional organic polymers
|
GB9025372D0
(en)
*
|
1990-11-22 |
1991-01-09 |
Nat Res Dev |
Pharmaceutical dosage forms
|
EP0585368B1
(de)
*
|
1991-04-25 |
1997-08-06 |
Brown University Research Foundation |
Implantierbare, biokompatible immunisolator-trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
|
US5800829A
(en)
*
|
1991-04-25 |
1998-09-01 |
Brown University Research Foundation |
Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
|
US6503277B2
(en)
|
1991-08-12 |
2003-01-07 |
Peter M. Bonutti |
Method of transplanting human body tissue
|
EP1243652A3
(de)
|
1991-09-20 |
2003-03-26 |
Amgen Inc., |
Glial neurotropher Faktor
|
US20040175795A1
(en)
*
|
1991-09-20 |
2004-09-09 |
Amgen Inc. |
Glial derived neurotrophic factor
|
AU3124793A
(en)
*
|
1991-10-29 |
1993-06-07 |
Clover Consolidated, Limited |
Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
|
US5573934A
(en)
*
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
JP3011768B2
(ja)
*
|
1992-02-28 |
2000-02-21 |
ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム |
組織接触材料および制御放出キャリアとしての光重合性生分解性親水ゲル
|
WO1994003154A1
(en)
*
|
1992-07-29 |
1994-02-17 |
Washington University |
Use of pouch for implantation of living cells
|
US5245896A
(en)
*
|
1992-08-19 |
1993-09-21 |
Kennametal Inc. |
Quick-change tool holder with center height adjustment mechanism
|
US5871985A
(en)
*
|
1992-09-28 |
1999-02-16 |
Brown University Research Foundation |
Particulate non cross-linked chitosan core matrices for encapsulated cells
|
WO1994007999A1
(en)
*
|
1992-09-28 |
1994-04-14 |
Brown University Research Foundation |
Chitosan matrices for encapsulated cells
|
FR2696658B1
(fr)
*
|
1992-10-14 |
1994-11-18 |
Hospal Ind |
Procédé et dispositif d'encapsulation d'une substance, ainsi que capsule obtenue.
|
WO1994025503A1
(en)
*
|
1993-04-27 |
1994-11-10 |
Cytotherapeutics, Inc. |
Membrane formed by an acrylonitrile-based polymer
|
NZ269041A
(en)
*
|
1993-06-23 |
1998-02-26 |
Univ Brown Res Found |
Implantable encapsulation device having a cell-tight dry seal at an opening thereof
|
DK0663817T3
(da)
*
|
1993-08-10 |
2000-03-13 |
Gore & Ass |
Celleindkapslingsindretning
|
US5908623A
(en)
|
1993-08-12 |
1999-06-01 |
Cytotherapeutics, Inc. |
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
CA2169292C
(en)
*
|
1993-08-12 |
2010-11-23 |
E. Edward Baetge |
Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
US5620883A
(en)
*
|
1994-04-01 |
1997-04-15 |
The Johns Hopkins University |
Living cells microencapsulated in a polymeric membrane having two layers
|
US5550050A
(en)
|
1994-04-15 |
1996-08-27 |
Cytotherapeutics, Inc. |
Method for implanting encapsulated cells in a host
|
US5935849A
(en)
|
1994-07-20 |
1999-08-10 |
Cytotherapeutics, Inc. |
Methods and compositions of growth control for cells encapsulated within bioartificial organs
|
US5776747A
(en)
*
|
1994-07-20 |
1998-07-07 |
Cytotherapeutics, Inc. |
Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
|
US5834029A
(en)
*
|
1994-07-20 |
1998-11-10 |
Cytotherapeutics, Inc. |
Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
|
US6495364B2
(en)
*
|
1995-05-23 |
2002-12-17 |
Neurotech, S.A. |
Mx-1 conditionally immortalized cells
|
US5681740A
(en)
*
|
1995-06-05 |
1997-10-28 |
Cytotherapeutics, Inc. |
Apparatus and method for storage and transporation of bioartificial organs
|
US5728581A
(en)
*
|
1995-06-07 |
1998-03-17 |
Systemix, Inc. |
Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
|
US5837234A
(en)
*
|
1995-06-07 |
1998-11-17 |
Cytotherapeutics, Inc. |
Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
|
AU6854696A
(en)
*
|
1995-09-22 |
1997-04-09 |
Gore Hybrid Technologies, Inc. |
Improved cell encapsulation device
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
US6184200B1
(en)
|
1995-09-28 |
2001-02-06 |
Amgen Inc. |
Truncated glial cell line-derived neurotrophic factor
|
US5855613A
(en)
*
|
1995-10-13 |
1999-01-05 |
Islet Sheet Medical, Inc. |
Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
|
DE19539361A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
US5641750A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US5641749A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
|
US6110707A
(en)
*
|
1996-01-19 |
2000-08-29 |
Board Of Regents, The University Of Texas System |
Recombinant expression of proteins from secretory cell lines
|
US6087129A
(en)
|
1996-01-19 |
2000-07-11 |
Betagene, Inc. |
Recombinant expression of proteins from secretory cell lines
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US6027721A
(en)
*
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
AU708536B2
(en)
*
|
1996-05-21 |
1999-08-05 |
Cytotherapeutics, Inc. |
System and method for delivery of cytokines using encapsulated cytokine-secreting cells
|
US6054142A
(en)
*
|
1996-08-01 |
2000-04-25 |
Cyto Therapeutics, Inc. |
Biocompatible devices with foam scaffolds
|
FR2753086B1
(fr)
*
|
1996-09-12 |
1999-02-26 |
Hospal R & D Int |
Dispositif et procede de fabrication d'une capsule tubulaire segmentee contenant un milieu biologiquement actif
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
US6306491B1
(en)
|
1996-12-20 |
2001-10-23 |
Gore Enterprise Holdings, Inc. |
Respiratory aids
|
FR2766088B1
(fr)
*
|
1997-07-17 |
2001-01-05 |
Dow Corning Sa |
Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire
|
US6347930B1
(en)
*
|
1997-09-11 |
2002-02-19 |
Hospal R & D Int. |
Device and method for manufacturing a segmented tubular capsule containing a biologically active medium
|
US6303136B1
(en)
|
1998-04-13 |
2001-10-16 |
Neurotech S.A. |
Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
|
US5973119A
(en)
*
|
1998-06-05 |
1999-10-26 |
Amgen Inc. |
Cyclin E genes and proteins
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
US6322962B1
(en)
|
1998-08-14 |
2001-11-27 |
Board Of Regents, The University Of Texas System |
Sterol-regulated Site-1 protease and assays of modulators thereof
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
US6303749B1
(en)
|
1999-01-29 |
2001-10-16 |
Amgen Inc. |
Agouti and agouti-related peptide analogs
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
US8624010B1
(en)
|
1999-02-03 |
2014-01-07 |
Steven K. Yoshinaga |
Nucleic acids encoding B7RP1
|
US7708993B2
(en)
|
1999-02-03 |
2010-05-04 |
Amgen Inc. |
Polypeptides involved in immune response
|
SI2332976T1
(sl)
|
1999-02-03 |
2014-08-29 |
Amgen Inc. |
Novi polipeptidi, vkljuäśeni v imunskem odgovoru
|
US7745216B2
(en)
|
1999-02-10 |
2010-06-29 |
Curis, Inc. |
Methods and reagents for treating glucose metabolic disorders
|
JP2003518914A
(ja)
|
1999-02-10 |
2003-06-17 |
キュリス インコーポレイテッド |
グルコース代謝障害を治療する方法および試薬
|
US6365385B1
(en)
|
1999-03-22 |
2002-04-02 |
Duke University |
Methods of culturing and encapsulating pancreatic islet cells
|
US6303355B1
(en)
|
1999-03-22 |
2001-10-16 |
Duke University |
Method of culturing, cryopreserving and encapsulating pancreatic islet cells
|
AU3770800A
(en)
|
1999-03-26 |
2000-10-16 |
Amgen, Inc. |
Beta secretase genes and polypeptides
|
US20070071734A1
(en)
*
|
1999-04-06 |
2007-03-29 |
Weng Tao |
ARPE-19 as platform cell line for encapsulated cell-based delivery
|
US6361771B1
(en)
|
1999-04-06 |
2002-03-26 |
Neurotech S.A. |
ARPE-19 as a platform cell line for encapsulated cell-based delivery
|
US7408047B1
(en)
|
1999-09-07 |
2008-08-05 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
AU781265B2
(en)
*
|
1999-09-30 |
2005-05-12 |
Unisearch Limited |
Method and apparatus for culturing cells
|
AUPQ319199A0
(en)
*
|
1999-09-30 |
1999-10-28 |
Unisearch Limited |
Method and apparatus for culturing cells
|
US6878543B1
(en)
*
|
1999-10-25 |
2005-04-12 |
Nsgene Sa |
Cultures of GFAP+ nestin+ cells that differentiate to neurons
|
US6365171B1
(en)
|
1999-11-04 |
2002-04-02 |
The University Of Akron |
Amphiphilic networks, implantable immunoisolatory devices and methods of preparation
|
US7635390B1
(en)
|
2000-01-14 |
2009-12-22 |
Marctec, Llc |
Joint replacement component having a modular articulating surface
|
US20030103978A1
(en)
|
2000-02-23 |
2003-06-05 |
Amgen Inc. |
Selective binding agents of osteoprotegerin binding protein
|
FI111057B
(fi)
|
2000-05-29 |
2003-05-30 |
Conenor Oy |
Ekstruusiomenetelmä ja ekstruusiolaite
|
WO2002000724A2
(en)
|
2000-06-28 |
2002-01-03 |
Amgen, Inc. |
Thymic stromal lymphopoietin receptor molecules and uses thereof
|
JP4236925B2
(ja)
|
2000-11-28 |
2009-03-11 |
アムジエン・インコーポレーテツド |
免疫応答に関与する新規ポリペプチド
|
BR0116206A
(pt)
|
2000-12-14 |
2003-12-23 |
Amylin Pharmaceuticals Inc |
Peptìdeo yy e agonistas de peptìdeo yy para tratamento de distúrbios metabólicos
|
US7442370B2
(en)
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
US7276580B2
(en)
*
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
EP1639972B1
(de)
|
2001-08-01 |
2013-09-11 |
Anecova SA |
Intrauterine Vorrichtung
|
CA2456070C
(en)
*
|
2001-08-01 |
2008-05-20 |
Pascal Mock |
Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity
|
US7662924B2
(en)
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
NZ537220A
(en)
*
|
2002-05-16 |
2008-06-30 |
Absorber Ab |
Method of isolating an endothelial cell and method of donor specific crossmatching
|
JP4571776B2
(ja)
*
|
2002-11-05 |
2010-10-27 |
Jx日鉱日石エネルギー株式会社 |
潤滑油組成物
|
ATE433759T1
(de)
|
2003-04-18 |
2009-07-15 |
Biogen Idec Inc |
Polymerkonjugiertes glycosiliertes neublastin
|
ATE423134T1
(de)
|
2003-06-10 |
2009-03-15 |
Nsgene As |
Verbesserte sezernierung von neublastin
|
US8501473B2
(en)
|
2003-07-16 |
2013-08-06 |
Evotec International Gmbh |
Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
|
WO2005033297A1
(en)
*
|
2003-09-19 |
2005-04-14 |
The Rockefeller University |
Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
|
DE602004025959D1
(de)
|
2003-10-20 |
2010-04-22 |
Nsgene As |
Viraler Vektor zur Verwendung in der in-vivo-Gentherapie von Morbus Parkinson
|
ATE409741T1
(de)
*
|
2004-01-19 |
2008-10-15 |
Nsgene As |
Nervenwachstumsfaktor sezernierende menschliche therapeutische zellen
|
JP5638177B2
(ja)
|
2004-02-11 |
2014-12-10 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
膵臓ポリペプチドファミリーモチーフおよびそのモチーフを含むポリペプチド
|
EP1737949B1
(de)
*
|
2004-03-09 |
2010-09-15 |
Absorber AB |
Endothelvorläuferzellen und verfahren zur verwendung davon
|
EP2289911A3
(de)
|
2004-03-30 |
2011-03-30 |
NsGene A/S |
Therapeutische Verwendung des Wachstumsfaktors nsg33
|
US20090136552A1
(en)
*
|
2004-07-30 |
2009-05-28 |
Mette Gronborg |
Growth factors nsg28, nsg30, and nsg32
|
CA2577755C
(en)
*
|
2004-08-19 |
2014-05-13 |
Biogen Idec Ma Inc. |
Neublastin variants
|
JP4959566B2
(ja)
*
|
2004-08-19 |
2012-06-27 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
トランスホーミング増殖因子βファミリータンパク質の折りたたみ
|
WO2006074075A2
(en)
|
2004-12-30 |
2006-07-13 |
Primegen Biotech, Llc |
Adipose-derived stem cells for tissue regeneration and wound healing
|
CN101155912A
(zh)
*
|
2005-01-31 |
2008-04-02 |
同源治疗公司 |
显示出内皮细胞特征的脂肪来源的成年基质细胞
|
CN103361303B
(zh)
|
2005-03-31 |
2015-09-30 |
斯丹姆涅恩有限公司 |
制备一种高度纯化来自羊膜的细胞群的方法
|
AU2006228873B2
(en)
*
|
2005-04-01 |
2011-08-18 |
Nsgene A/S |
A human immortalised neural precursor cell line
|
US20080207594A1
(en)
|
2005-05-04 |
2008-08-28 |
Davelogen Aktiengesellschaft |
Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders
|
EP1883446B8
(de)
*
|
2005-05-17 |
2017-11-15 |
Gloria Therapeutics Sarl |
Implantierbares therapiesystem zur behandlung eines lebewesens mit einem wirkfaktor
|
PT2314623E
(pt)
|
2005-06-21 |
2012-10-02 |
Xoma Technology Ltd |
Anticorpos de ligação a il-1β e os seus fragmentos
|
TW200726474A
(en)
*
|
2005-07-15 |
2007-07-16 |
Cognate Therapeutics Inc |
The immunophenotype and immunogenicity of human adipose derived cells
|
US8357666B2
(en)
*
|
2005-08-01 |
2013-01-22 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through RNA interference
|
WO2007048413A1
(en)
*
|
2005-10-28 |
2007-05-03 |
Nsgene A/S |
IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF
|
DE602005023550D1
(de)
|
2005-12-14 |
2010-10-21 |
Licentia Ltd |
Verwendungen eines neurotrophischen Faktors
|
JP5247468B2
(ja)
*
|
2005-12-30 |
2013-07-24 |
ニューロテック ユーエスエー, インコーポレイテッド |
生物活性分子の送達のための微粒子化デバイスおよびその使用方法
|
TWI501774B
(zh)
*
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
US20100056440A1
(en)
*
|
2006-03-01 |
2010-03-04 |
Biogen Idec Ma Inc. |
Compositions and methods for administering gdnf ligand family proteins
|
EP2051726B1
(de)
|
2006-07-18 |
2018-04-18 |
University of Utah Research Foundation |
Verfahren zur behandlung von schmerzen und screening von analgetischen verbindungen
|
EP2118267B1
(de)
|
2007-01-17 |
2017-03-15 |
Noveome Biotherapeutics, Inc. |
Neuartige verfahren zur modulation von entzündungs- und/oder immunreaktionen
|
WO2008120107A2
(en)
|
2007-04-03 |
2008-10-09 |
Oxyrane (Uk) Limited |
Glycosylation of molecules
|
US8329655B2
(en)
*
|
2007-05-01 |
2012-12-11 |
Biogen Idec Ma Inc. |
Methods for increasing vascularization
|
EP2205634A2
(de)
*
|
2007-08-08 |
2010-07-14 |
Biogen Idec MA, Inc. |
Anti-neublastin-antikörper und anwendungen davon
|
FI20070808A0
(fi)
|
2007-10-25 |
2007-10-25 |
Mart Saarma |
GDNF:n silmukointivariantit ja niiden käytöt
|
US20090196854A1
(en)
*
|
2008-02-04 |
2009-08-06 |
Kytos Biosystems S.A. |
Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
|
WO2009126250A2
(en)
|
2008-04-07 |
2009-10-15 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through rna interference
|
FI20080326A0
(fi)
|
2008-04-30 |
2008-04-30 |
Licentia Oy |
Neurotroofinen tekijä MANF ja sen käytöt
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
WO2009152084A2
(en)
|
2008-06-11 |
2009-12-17 |
Cell4Vet Llc |
Adipose tissue-derived stem cells for veterinary use
|
EA032727B1
(ru)
|
2008-10-10 |
2019-07-31 |
Амген Инк. |
Мутантный резистентный к протеолизу полипептид fgf21 и его применение
|
EP2356227B1
(de)
|
2008-11-14 |
2018-03-28 |
Viacyte, Inc. |
Einkapselung von aus menschlichen pluripotenten stammzellen abgeleiteten pankreaszellen
|
US20100158878A1
(en)
*
|
2008-12-23 |
2010-06-24 |
Alexandra Capela |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
JP5897335B2
(ja)
|
2009-01-23 |
2016-03-30 |
エヌエスジーン・アクティーゼルスカブNsGene A/S |
改良された細胞株及びカプセル化細胞生体送達におけるその使用
|
US20120021039A1
(en)
|
2009-01-23 |
2012-01-26 |
Nsgene A/S |
Expression of neuropeptides in mammalian cells
|
EP2230248A1
(de)
|
2009-03-03 |
2010-09-22 |
Assistance Publique - Hôpitaux de Paris |
Verfahren zur Erhöhung des Pools von NGN3+-endokrinen Vorläuferzellen und Zellmasse der endokrinen Pankreas
|
WO2010111278A1
(en)
|
2009-03-23 |
2010-09-30 |
The Texas A&M University System |
Compositions of mesenchymal stem cells to regenerate bone
|
US20150024024A1
(en)
*
|
2009-04-23 |
2015-01-22 |
Neurotech Usa, Inc. |
Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses Thereof
|
US20120052069A1
(en)
|
2009-05-05 |
2012-03-01 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
HRP20240135T1
(hr)
|
2009-05-05 |
2024-04-12 |
Amgen Inc. |
Fgf21 mutanti i njihove upotrebe
|
BRPI0902039B8
(pt)
|
2009-06-09 |
2021-05-25 |
Anhanguera Educacional Ltda |
composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais
|
WO2011039634A2
(en)
|
2009-09-29 |
2011-04-07 |
Universiteit Gent |
Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose
|
CA2776748A1
(en)
*
|
2009-10-08 |
2011-04-14 |
Neurotech Usa, Inc. |
Use of pedf in an encapsulated cell-based delivery system
|
EP2501805B1
(de)
|
2009-11-19 |
2019-02-20 |
Oxyrane UK Limited |
Hefe stämme die säugetier-ähnliche n-glykane produzieren
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
AR081743A1
(es)
|
2010-03-26 |
2012-10-17 |
Philip Morris Prod |
Fabricacion de capsulas de nucleo/caparazon de diferentes geometrias y tratamiento a partir de las mismas
|
AU2011239689A1
(en)
|
2010-04-15 |
2012-11-08 |
Amgen Inc. |
Human FGF receptor and beta-Klotho binding proteins
|
JP5988961B2
(ja)
|
2010-04-28 |
2016-09-07 |
ザ ジェイ. デヴィッド グラッドストーン インスティテューツ |
心筋細胞を発生させるための方法
|
ES2685171T3
(es)
|
2010-06-14 |
2018-10-05 |
The Scripps Research Institute |
Reprogramación de células a un nuevo destino
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
BR112013007263A2
(pt)
|
2010-09-29 |
2016-06-14 |
Oxyrane Uk Ltd |
desmanosilação de n-glicanos fosforilados
|
CA2812870C
(en)
|
2010-09-29 |
2020-06-09 |
Oxyrane Uk Limited |
Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
|
CN103269708A
(zh)
|
2010-10-01 |
2013-08-28 |
Ns基因公司 |
镍纹蛋白用于治疗异常性疼痛、痛觉过敏、自发性疼痛和幻痛的用途
|
US9725689B2
(en)
|
2010-10-08 |
2017-08-08 |
Terumo Bct, Inc. |
Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
US9149427B2
(en)
|
2010-12-02 |
2015-10-06 |
Neurotech Usa, Inc. |
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
|
WO2012084999A1
(en)
|
2010-12-21 |
2012-06-28 |
Universite De Strasbourg |
Prokineticin 1 receptor agonists and their uses
|
EP2468280A1
(de)
|
2010-12-21 |
2012-06-27 |
Université de Strasbourg |
Verwendung von Prokineticin-1-Rezeptoragonisten zur Unterstützung der Differenzierung von Epicardin und Vorläuferzellen
|
US20140134195A1
(en)
|
2011-04-20 |
2014-05-15 |
University Of Washington Through Its Center For Commercialization |
Beta-2 microglobulin-deficient cells
|
TWI535455B
(zh)
|
2011-06-06 |
2016-06-01 |
奇尼塔一有限責任公司 |
以shk為主之醫藥組合物及其製備方法及用途
|
US20150119399A1
(en)
|
2012-01-10 |
2015-04-30 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
EP3628326B1
(de)
|
2012-03-15 |
2024-02-28 |
Oxyrane UK Limited |
Verfahren und materialien zur behandlung von morbus pompe
|
JP2015514421A
(ja)
|
2012-04-17 |
2015-05-21 |
ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォーコマーシャライゼーションThe University Of Washington Through Its Center For Commercialization |
Hlaクラスiiタンパク質の発現能を有するhlaクラスii欠損細胞、hlaクラスi欠損細胞、及びその使用
|
JP2015519370A
(ja)
|
2012-05-30 |
2015-07-09 |
ニューロテック ユーエスエー, インコーポレイテッド |
低温保存される植込み型細胞培養デバイスおよびその使用
|
US9402710B2
(en)
*
|
2012-07-16 |
2016-08-02 |
The Board Of Trustees For The Leland Stanford Junior University |
Macroporous 3-D scaffolds for tissue engineering
|
CA2880811C
(en)
|
2012-08-01 |
2021-12-07 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
|
CA2880808C
(en)
|
2012-08-01 |
2023-01-24 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
|
EP3415150B1
(de)
|
2013-01-09 |
2021-08-18 |
United Therapeutics Corporation |
Behandlung von vaskulopathie mit prostacyclin und mesenchymalen stammzellen
|
WO2014136065A2
(en)
|
2013-03-05 |
2014-09-12 |
Oxyrane Uk Limited |
Production of catalytically active type i sulfatase
|
JP6234485B2
(ja)
|
2013-03-07 |
2017-11-22 |
ヴィアサイト インコーポレイテッド |
3次元大収容力細胞封入デバイスアセンブリー
|
USD720469S1
(en)
|
2013-03-07 |
2014-12-30 |
Viacyte, Inc. |
Cell encapsulation device
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
JOP20140087B1
(ar)
|
2013-03-13 |
2021-08-17 |
Amgen Inc |
بروتينات مخصصة ل baff و b7rp1 وإستخداماتها
|
CA2913993A1
(en)
|
2013-05-31 |
2014-12-04 |
University Of Utah Research Foundation |
Conotoxin peptides, pharmaceutical compositions and uses thereof
|
AU2014318846A1
(en)
|
2013-09-11 |
2016-03-10 |
Neurotech Usa, Inc. |
Encapsulated cell therapy cartridge
|
WO2015042580A1
(en)
|
2013-09-23 |
2015-03-26 |
Biogen Idec Ma Inc. |
Compositions and methods for treatment of neuropathic pain
|
CN106715676A
(zh)
|
2014-09-26 |
2017-05-24 |
泰尔茂比司特公司 |
按计划供养
|
EP3220996B1
(de)
|
2014-11-20 |
2022-01-05 |
ViaCyte, Inc. |
Instrumente und verfahren zum laden von zellen in implantierbare geräte
|
ES2833457T3
(es)
|
2015-05-27 |
2021-06-15 |
Neurotech Usa Inc |
Uso de terapia con células encapsuladas para el tratamiento del glaucoma
|
US20160361380A1
(en)
|
2015-06-12 |
2016-12-15 |
Nymox Corporation |
Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
|
EP3464565A4
(de)
|
2016-05-25 |
2020-01-01 |
Terumo BCT, Inc. |
Zellexpansion
|
US10183058B2
(en)
|
2016-06-17 |
2019-01-22 |
Nymox Corporation |
Method of preventing or reducing the progression of prostate cancer
|
AU2017300590A1
(en)
|
2016-07-18 |
2019-01-24 |
Eth Zurich |
B-cell-mimetic cells
|
EP3272877A1
(de)
|
2016-07-18 |
2018-01-24 |
ETH Zurich |
B-zell-mimetische zellen
|
US10172910B2
(en)
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|
US10532081B2
(en)
|
2016-09-07 |
2020-01-14 |
Nymox Corporation |
Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
|
ES2927406T3
(es)
|
2016-10-24 |
2022-11-04 |
United Therapeutics Corp |
Potenciación de las propiedades inmunomoduladoras de las MSC mediante treprostinil
|
JP7088564B2
(ja)
|
2016-11-10 |
2022-06-21 |
ヴィアサイト,インコーポレイテッド |
細胞送達装置におけるpdx1膵臓内胚葉細胞及びその方法
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
JP7393945B2
(ja)
|
2017-03-31 |
2023-12-07 |
テルモ ビーシーティー、インコーポレーテッド |
細胞増殖
|
GB2569266A
(en)
*
|
2017-10-13 |
2019-06-19 |
Nottingham Univ Hospitals Nhs Trust |
Methods of forming solid or liquid charged capsules
|
WO2022011081A1
(en)
|
2020-07-09 |
2022-01-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cell lines that produce human retinoschisin proteins and uses thereof
|
WO2023164171A2
(en)
|
2022-02-25 |
2023-08-31 |
Viacyte, Inc. |
Multilayer implantable cell encapsulation devices and methods thereof
|